| Overall survival | Progression Free Survival | Local Control Rates | ||||
| N | 2 years OS (%) | P | 2 years PFS (%) | P | 2 years LCR (%) | P |
Age |
|
|
|
|
|
|
|
60≥ | 122 | 85.9 | 0.322 | 68.1 | 0.435 | 85.3 | 0.026 |
60< | 56 | 73.2 | 69.3 | 97.8 | |||
Stage |
|
|
|
|
|
|
|
IB2-IIA | 21 | 100 | 0.027 | 83.9 | 0.072 | 90.9 | 0.446 |
IIB-IV | 157 | 79.8 | 66.5 | 88.6 | |||
Tm diameter |
|
|
|
|
|
|
|
4≥ | 45 | 90.9 | 0.5 | 79.4 | 0.021 | 93.9 | 0.207 |
4< | 133 | 79.1 | 65 | 87.3 | |||
Residual tm |
|
|
|
|
|
|
|
Positive | 32 | 63.5 | <0.0005 | 32.1 | <0.0005 | 69.4 | 0.001 |
Negative | 146 | 85.2 | 74.8 | 91.9 | |||
Presence of residual tumor |
|
|
|
|
|
|
|
Central | 13 | 80.8 | 0.386 | 7.7 | 0.201 | 7.7 | 0.580 |
Peripheral | 4 | 33.3 | 25 | 25 | |||
Menopausal st. |
|
|
|
|
|
|
|
Pre- | 78 | 84.7 | 0.864 | 69.2 | 0.544 | 88.5 | 0.198 |
Post- | 100 | 79.8 | 67.8 | 90.7 | |||
Chemotherapy (CHT) |
|
|
|
|
|
|
|
Positive | 134 | 85.3 | 0.005 | 90.1 | 0.040 | 92.8 | 0.375 |
Negative | 44 | 69.1 | 51.3 | 91.6 | |||
Number of CHT |
|
|
|
|
|
|
|
5≤ | 80 | 89 | 0.759 | 76 | 0.588 | 89.1 | 0.656 |
5> | 54 | 77.5 | 67.8 | 86.9 |